Antidiabetics Market Research
Emergence and prevalence of diabetes mellitus are increasing worldwide, in line with lifestyle changes and population aging. Diabetes affects approximately 170 million people worldwide and is increasing, with the WHO predicting 300 million diabetics across the globe, by 2025.
The antidiabetics market in the seven major markets is expected to grow from $22,806 million in 2009 to $34.8 billion in 2019, with a 4% CAGR. Growth is driven by the epidemiological expansion of the market, fuelled by the obesity epidemic and improved diagnosis rates. Significant unmet needs remain in diabetes fueling a large pipeline. The epidemiological growth of the market, driven by the obesity epidemic and improved diagnosis rates, is further driving the market.
The Antidiabetics market research involves quantifying the future size of the antidiabetics market from 2010-2019 and identifying opportunities for new products. It also includes examining the future performance of leading antidiabetic brands and the growth of generics and insulin biosimilars, apart from understanding the barriers to uptake for novel antidiabetic agents.